International Medical Corps dreamt of the perfect solution to help injured disaster survivors — a portable, rapidly deployable, fully functional hospital. Rebecca Milner explains how FedEx helped to make the impossible possible.
Pharmaceutical companies have long experience in measuring the impact of their business programs. The same should apply to their access-to-medicine efforts
Richard Laing, from the Boston University (BU) School of Public Health and former World Health Organization official, says that many efforts to expand access to medicines fail to gather sufficient evidence on how effective they are. His team at BU recently issued a study highlighting these gaps, and emphasizing the need for companies to better document the impact of their programs.
Making our cities into places of wellbeing, exciting growth and opportunity will require every sector to join forces on urban health, says Dr. Ann Aerts, Head of the Novartis Foundation.
By Dr. Ann Aerts, Head of the Novartis Foundation
Walking through the wealthier streets of cities like Geneva, London or New York, it seems that health and fitness is an international obsession. National food chains boast of fresh ingredients, light options, and low-fat meals. Shelves are stacked with the trendiest superfoods – quinoa, chia seeds, kale and avocado.
Better Hearts Better Cities is an initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension
Better Hearts Better Cities is a Novartis Foundation initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension.
Non-communicable diseases (NCDs), including cardiovascular disease, are a growing health crisis with 75% of NCD deaths occurring in low- and middle-income countries; this is compounded by rapid urbanization.
The innovative approach is being tested on three continents: in Mongolia, Senegal, and Brazil.
“Big Data,” the phenomenon every industry and professional is hailing as the next great innovation-driver, has its origins in part in the healthcare industry. In today’s fast-paced environment, Big Data is likely to play an increasing role in helping hospitals stay ahead of the curve in the ever-changing healthcare industry.
Novartis reaches agreement with Pakistan to supply medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation.
May 12, 2017 /3BL Media/ -- We are pleased to announce that Novartis and the Ministry of National Health Services, Regulation and Coordination of the Islamic Republic of Pakistan have signed a Memorandum of Understanding to implement Novartis Access in Pakistan. Novartis Access medicines will be made available to the poorest population through hospitals under the Prime Minister’s National Health Insurance Program.
DRINKiQ e-Learning Module Unlocks Knowledge of How Alcohol Affects the Body
NORWALK, Conn., May 11, 2017 /3BL Media/– Diageo, the global leader in beverage alcohol, announced today the public launch of an online e-learning module called DRINKiQ designed to provide consumers with the information they need to make informed decisions about drinking responsibly.
These are uncertain times for the future of health in the U.S. The context continues to shift with amendments to the original failed American Health Care Act (AHCA) bill under constant discussion, and swirling speculation about a vote on a new bill this week before Congress goes on recess.
The Internet of Things (IoT) is changing the way we live. Connected devices like our phones, watches, lights, and even televisions are communicating to make our lives better. My thermostat warms my home before I arrive, my light bulbs detect when I've pulled into my driveway and switch on, and my watch can secure my home before I go to bed.
FOSTER CITY, Calif., May 1, 2017 /3BL Media/ - Gilead Sciences, Inc. today announced that it issued its Year in Review 2016 report, a combination of the company’s Annual Report and Corporate Social Responsibility report. This report provides an in-depth look into Gilead’s commitment to develop and deliver innovative therapies that change lives.
The report focuses on four key areas: giving and access, people, products and environment as well as a financial overview. Highlights include: